New Orleans - Determining the relative risk of a cutaneous drug reaction pattern is vital to determining whether the drug(s) in question can be continued currently or rechallenged in the future,
Derm In The News: May 12-18
The Cutaneous Connection: A Reminder of Patient Impact
Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Dermatophytoma: A Diagnosis That You Do Not Want to Miss
QUIZ RECAP: Advanced Skin Cancer Awareness